Spots Global Cancer Trial Database for upper tract urothelial carcinoma
Every month we try and update this database with for upper tract urothelial carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC | NCT02876861 | High-Grade Uppe... | Radical nephrou... Distal ureterec... Neoadjuvant Che... | 18 Years - 80 Years | Xiangya Hospital of Central South University | |
Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma | NCT01606345 | Urothelial Carc... | Valrubicin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients | NCT02923557 | Bladder Recurre... Upper Tract Uro... Nephroureterect... | Pirarubicin | 18 Years - | Peking University First Hospital | |
Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC | NCT02876861 | High-Grade Uppe... | Radical nephrou... Distal ureterec... Neoadjuvant Che... | 18 Years - 80 Years | Xiangya Hospital of Central South University | |
Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL) | NCT04574960 | Bladder Cancer Bladder Urothel... | Gemcitabine Cisplatin Carboplatin | 18 Years - | University Health Network, Toronto | |
Feasibility and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial Carcinoma | NCT03544437 | Upper Tract Uro... | extraperitoneal... | 15 Years - 80 Years | RenJi Hospital | |
Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11) | NCT03617003 | Upper Tract Uro... | WST11 mediated ... Endoscopy | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy | NCT06204406 | Upper Tract Uro... | Observational | 18 Years - 90 Years | RenJi Hospital | |
Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC) | NCT05837806 | Neoadjuvant Imm... | tislelizumab+di... | 18 Years - | Tianjin Medical University Second Hospital | |
Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy. | NCT02438865 | Neoplasm, Urete... Neoplasm, Bladd... | Immediate insti... Maintainance th... | - | Mansoura University | |
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection | NCT04948528 | Upper Tract Uro... | Active Comparat... Active Comparat... | 18 Years - | AnchorDx Medical Co., Ltd. | |
Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study | NCT04702347 | Urologic Cancer Urologic Neopla... | Urine biomarker | 18 Years - | Fundacio Puigvert | |
Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma) | NCT03230201 | Recurrence Metastasis Upper Tract Uro... Lymph Node Diss... | Lymph node diss... | - | Peking University First Hospital | |
Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy | NCT06204406 | Upper Tract Uro... | Observational | 18 Years - 90 Years | RenJi Hospital | |
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection | NCT04948528 | Upper Tract Uro... | Active Comparat... Active Comparat... | 18 Years - | AnchorDx Medical Co., Ltd. | |
Neoadjuvant Nivolumab for Upper Tract Urothelial Carcinoma | NCT05160285 | Upper Urinary T... | Nivolumab 100 M... | 20 Years - 85 Years | Chang Gung Memorial Hospital | |
Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma) | NCT03230201 | Recurrence Metastasis Upper Tract Uro... Lymph Node Diss... | Lymph node diss... | - | Peking University First Hospital | |
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas | NCT02547350 | Upper Tract Uro... Bladder Recurre... | pharmorubicin o... | - | Peking University First Hospital | |
Circulating Tumour DNA and Urine Tumor DNA Detection of Minimal Residual Disease in Locally Advanced Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy: A Cohort Study | NCT05595408 | Muscle Invasive... | Adjuvant chemot... adjuvant immuno... | 18 Years - | RenJi Hospital | |
Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study | NCT04702347 | Urologic Cancer Urologic Neopla... | Urine biomarker | 18 Years - | Fundacio Puigvert | |
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas | NCT02547350 | Upper Tract Uro... Bladder Recurre... | pharmorubicin o... | - | Peking University First Hospital | |
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients | NCT02740426 | Upper Tract Uro... Bladder Recurre... | Pirarubicin | 18 Years - | Peking University First Hospital |